Locally Advanced Unresectable Triple-Negative Breast Carcinoma
1 clinical trials · Condition
◉ Watch Locally Advanced Unresectable Triple-Negative Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer (NCT06434064) | Roswell Park Cancer Institute | 2026-03-03 |
Track Locally Advanced Unresectable Triple-Negative Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.